News
Media
Podcasts
Conferences
Journals
Events
CME
Partners
Subscribe
Resources

Spotlight -

Zeiss Clinical Cases

Viewing

Opinion|Videos|August 16, 2023

Emerging Therapies for Dry Eye Disease

Author(s)William B. Trattler, MD, Crystal Brimer, OD, FAAO, Cynthia Matossian, MD, FACS, ABES

Crystal Brimer, OD, and Kelly K. Nichols, OD, MPH, PhD, discuss two treatments, AZR-MD-001 and Reproxalap, that are in the pipeline to treat patients with dry eye disease (DED).

Episodes in this series

EP. 1 The Prevalence and Impact of Dry Eye Disease

EP. 1 The Prevalence and Impact of Dry Eye Disease

EP. 2 The Impact of Dry Eye Disease on Coexisting Ocular Conditions

EP. 2 The Impact of Dry Eye Disease on Coexisting Ocular Conditions

EP. 3 Clinical Perspectives on Standard Use of Dry Eye Disease Questionnaire

EP. 3 Clinical Perspectives on Standard Use of Dry Eye Disease Questionnaire

EP. 4 Diagnostic Tests for Dry Eye Disease

EP. 4 Diagnostic Tests for Dry Eye Disease

EP. 5 Dry Eye Treatment Approaches and the Use of Artificial Tears

EP. 5 Dry Eye Treatment Approaches and the Use of Artificial Tears

EP. 6 Anti-Inflammatory Therapies for Dry Eye Disease

EP. 6 Anti-Inflammatory Therapies for Dry Eye Disease

EP. 7 Factors to Consider in Choosing Anti-Inflammatory Therapies for Dry Eye Disease

EP. 7 Factors to Consider in Choosing Anti-Inflammatory Therapies for Dry Eye Disease

$EP. 8 Managing Patients With Dry Eye Disease Pre-Cataract or Refractive Surgery$

EP. 8 Managing Patients With Dry Eye Disease Pre-Cataract or Refractive Surgery

EP. 9 Developing Treatment Algorithm for Dry Eye Disease.

EP. 9 Developing Treatment Algorithm for Dry Eye Disease.

EP. 10 Combining Procedural and Pharmacological Therapies in Dry Eye Disease

EP. 10 Combining Procedural and Pharmacological Therapies in Dry Eye Disease

EP. 11 New FDA-Approved Therapies and Diagnostics for Dry Eye Disease

EP. 11 New FDA-Approved Therapies and Diagnostics for Dry Eye Disease

EP. 12 Emerging Therapies for Dry Eye Disease

EP. 12 Emerging Therapies for Dry Eye Disease

EP. 13 Co-Management of Dry Eye Disease

EP. 13 Co-Management of Dry Eye Disease

EP. 14 Clinical Pearls for Management of Dry Eye Disease

EP. 14 Clinical Pearls for Management of Dry Eye Disease

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Content

Esen K. Akpek, MD | Ophthalmology Times Article

Bausch + Lomb survey ties dry eye symptom relief to quality of life gains

ByOphthalmology Times Staff

July 10th 2026

Ping Moore, OD | Ophthalmology Times

Understanding meibomian gland dysfunction, neuropathic pain, and the evolving dry eye patient

ByYun Ping Moore, OD,Lucia Gambuzza

July 8th 2026

Polyendocrine metabolic ovarian syndrome: looking past the reproductive system to the eye

ByLynda Charters

July 6th 2026

Shareen M. Greenbaum, MD & Amanda Amberg, OD | Ophthalmology Times

Dry Eye Awareness Month: building a strong optometry-ophthalmology co-management model

ByShareen M. Greenbaum, MD,Amanda Amberg, OD,Lucia Gambuzza

July 1st 2026

(Image credit: Ophthalmology Times) iOpeners with Nicole Bajic, MD: Nikolina Budimlija, MD, on building a multidisciplinary dry eye clinic in Ireland

iOpeners with Nicole Bajic, MD: Nikolina Budimlija, MD, on building a multidisciplinary dry eye clinic in Ireland

ByNicole Bajic, MD,Nikolina Budimlija, MD

June 23rd 2026

Latest CME

Retina Updates in Montréal

In-Person + Virtual Event

Retina Updates in Montréal

July 16-17, 2026

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

Solange Peters, MD, PhD; Benjamin P. Levy, MD; Tony S.K. Mok, MD, BMSc, FRCP(C), FRCP(Edin), FHKCP, FHKAM(Medicine), FASCO; Maurice Pérol, MD

PER Global Perspectives: Differentiating and Managing Toxicities with TROP2-Targeted ADCs in NSCLC Through Multidisciplinary Pathways

PER Global Perspectives: Differentiating and Managing Toxicities with TROP2-Targeted ADCs in NSCLC Through Multidisciplinary Pathways

Solange Peters, MD, PhD; Stephanie McDonald, FNP-BC, AOCNP; Antonio Passaro, MD, PhD; Jacob Sands, MD

Interventional Dry Eye: A Stepwise Treatment & Management Approach

Interventional Dry Eye: A Stepwise Treatment & Management Approach

Mark Schaeffer, OD, FAAO; Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO, FAAOMS; Selina R. McGee, OD, FAAO

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

SriniVas Sadda, MD, FARVO; Nathan Steinle, MD

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Mark R. Barakat, MD, FASRS; David Eichenbaum, MD, FASRS

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

Dante Pieramici, MD, FASRS; Dean Eliott, MD; Robin A. Vora, MD; Charles C. Wykoff, MD, PhD, FASRS

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

Dilsher Dhoot, MD, FASRS; Jordana G. Fein, MD, MS; Deep Parikh, MD; Xiao-Yi (Ellie) Zhou, MD

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

Ramiro Maldonado, MD; Rebecca Nelson, MS, CGC; Robert A. Sisk, MD, FACS, FASRS

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

David Almeida, MD, PhD, MBA; Margaret A. Chang, MD, MS; Arshad M. Khanani, MD, MA, FASRS; Jessica Randolph, MD

AREDS3 and Beyond: The Scientific Basis for B Vitamin Nutritional Supplementation in AMD

In-Person + Virtual Event

AREDS3 and Beyond: The Scientific Basis for B Vitamin Nutritional Supplementation in AMD

September 13, 2026

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

SriniVas R. Sadda, MD, FARVO; Mark R. Barakat, MD, FASRS; David A. Eichenbaum, MD, FASRS

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Basil Williams, MD; Maura Di Nicola, MD

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

John Kitchens, MD; Michael W. Stewart, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Dilsher S. Dhoot, MD, FASRS

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

Trending on Eye Care Network - Ophthalmology Times

Refractive cataract surgery: aiming for '20/happy' patients

Access Challenges in Retinal Vascular Diseases

Managing Retinal Vascular Diseases in Clinical Practice